| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JXHL0800015 | Enzastaurin | enzastaurin | Active ingredient | Chemical Drugs(1.1) | Import Drug Application | 2008-01-18 | 美国礼来亚洲公司北京办事处 | Eli Lilly & Company | Certificate Issued | 2008-11-28 | view |
| JXHL1700011 | Enzastaurin片 | enzastaurin | Tablet | Chemical Drugs(1) | Import Drug Application | 2017-01-26 | 索元生物医药（杭州）有限公司 | Denovo Biopharma Co Ltd;Denovo Biopharma LLC | Certificate Issued | 2017-10-12 | view |
| JXHL2000003 | Enzastaurin片 | enzastaurin | Tablet | Chemical Drugs(1) | Import Drug Application | 2020-01-17 | 索元生物医药（杭州）有限公司 | Denovo Biopharma Co Ltd;Denovo Biopharma LLC | In Review | 2020-01-16 | view |
| JXHB2000034 | Enzastaurin片 | enzastaurin | Tablet | Chemical Drugs(1) | Supplementary Application | 2020-09-25 | 索元生物医药（杭州）有限公司 | Denovo Biopharma Co Ltd;Xcelience LLC;Denovo Biopharma LLC | In Review | 2020-09-24 | view |